Chronic kidney disease (CKD) and NAFLD: Time for awareness and screening

Journal of Hepatology

Volumn 62, Issue 4, 2015, Pages 983-984

  Musso, Giovanni ^a   Tabibian, James H ^b   Charlton, Michael ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TACROLIMUS;

CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; HUMAN; HYPERTENSION; LETTER; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER HISTOLOGY; LIVER TRANSPLANTATION; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; SCREENING; ADVERSE EFFECTS; CHRONIC KIDNEY FAILURE; FEMALE; GLOMERULUS FILTRATION RATE; MALE; MORTALITY; POSTOPERATIVE COMPLICATION;

FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84926421634     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.11.044     Document Type: Letter

References (10)

1. A.M. Allen, W.R. Kim, T.M. Therneau, J.J. Larson, J.K. Heimbach, and A.D. Rule Chronic kidney disease and associated mortality after liver transplantation-a time-dependent analysis using measured glomerular filtration rate J Hepatol 61 2014 286 292
2. A.K. Singal, P. Guturu, B. Hmoud, Y.F. Kuo, H. Salameh, and R.H. Wiesner Evolving frequency and outcomes of liver transplantation based on etiology of liver disease Transplantation 95 2013 755 760
3. A.K. Singal, H. Salameh, Y.F. Kuo, and R.H. Wiesner Evolving frequency and outcomes of simultaneous liver kidney transplants based on liver disease etiology Transplantation 98 2014 216 221
4. D.D. Houlihan, M.J. Armstrong, Y. Davidov, J. Hodson, P. Nightingale, and I.A. Rowe Renal function in patients undergoing transplantation for nonalcoholic steatohepatitis cirrhosis: time to reconsider immunosuppression regimens? Liver Transpl 17 2011 1292 1298
5. G. Musso, R. Gambino, J.H. Tabibian, M. Ekstedt, S. Kechagias, and M. Hamaguchi Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis PLoS Med 11 2014 e1001680 10.1371/journal.pmed.1001680
6. C. Black, P. Sharma, G. Scotland, K. McCullough, and D. McGurn Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis Health Technol Assess 14 2010 1 184
7. J. Coresh, D. Byrd-Holt, B.C. Astor, J.P. Briggs, and P.W. Eggers Chronic kidney disease awareness, prevalence, and trends among US adults, 1999 to 2000 J Am Soc Nephrol 16 2005 180 188
8. V.G. Athyros, K. Tziomalos, T.D. Gossios, T. Griva, P. Anagnostis, and K. Kargiotis Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis Lancet 376 2010 1916 1922
9. T. Hirata, K. Tomita, T. Kawai, H. Yokoyama, A. Shimada, and M. Kikuchi Effect of Telmisartan or Losartan for Treatment of Nonalcoholic Fatty Liver Disease: Fatty Liver Protection Trial by Telmisartan or Losartan Study (FANTASY) Int J Endocrinol 2013 2013 Article ID: 587140
10. G. Musso, M. Cassader, F. Rosina, and R. Gambino Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials Diabetologia 55 2012 885 904